Atorvastatin Calcium Tablet, Coated
Product Images NDC 71209-092

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71209-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorva-fig-1 (Atorva Fig1)

A line graph displaying cumulative incidence percentages over a period of 3.5 years comparing Atorvastatin (solid line) and Placebo (dashed line). The graph includes hazard ratio and p-value statistics, illustrating a lower cumulative incidence for Atorvastatin compared to Placebo.*

FDA Label Image

Atorva-fig-2 (Atorva Fig2)

A line chart depicting cumulative hazard percentage over time (years) comparing Atorvastatin and placebo groups. The x-axis shows time to first primary endpoint through four years of follow-up, and the y-axis indicates cumulative hazard percentage. The chart includes hazard ratio (HR 0.63, 95% CI 0.48-0.83) and a p-value of 0.001, illustrating statistical analysis of the data.*

FDA Label Image

Atorva-fig-3 (Atorva Fig3)

A line graph displaying the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years up to 5 years, and the y-axis shows the percentage of subjects. Two lines indicate the event rates for each dose, with Atorvastatin 80 mg showing a slightly lower event rate over time.*

FDA Label Image

Atorvastatin-spl-strc (Atorvastatin Spl Strc)

Chemical structure of atorvastatin calcium showing its molecular components including multiple aromatic rings, hydroxyl groups, and carboxylate ions, representing the active ingredient in this prescription drug.*

FDA Label Image

Cont-label-500s-40mg.jpg (Cont Label 500s 40mg)

Label for Atorvastatin Calcium Tablets USP, 40 mg strength, coated tablets in a 500-tablet package. The label includes storage instructions, dosage caution, manufacturer details (Cadila Pharmaceuticals Limited, Ahmedabad, India), and a barcode. The label also highlights the Rx only status and the NDC number 71209-092-10.*

FDA Label Image

Cont-label-500s-80mg.jpg (Cont Label 500s 80mg)

Atorvastatin Calcium Tablets, USP label showing 80 mg strength in coated tablet form. The package contains 500 tablets and is marked Rx only. Labeler is Cadila Pharmaceuticals Limited, located in Ahmedabad, Gujarat State, India. Includes storage instructions and a barcode on the right side.*

FDA Label Image

Cont-label-90s-10mg.jpg (Cont Label 90s 10mg)

Atorvastatin Calcium Tablets, USP 10 mg coated oral tablets label from Cadila Pharmaceuticals Limited. The label indicates 90 tablets per container, storage instructions at 20° to 25°C, and includes a barcode and national drug code 71209-090-04. The product is Rx only and manufactured in Ahmedabad, India.*

FDA Label Image

Cont-label-90s-20mg.jpg (Cont Label 90s 20mg)

Atorvastatin Calcium Tablets, USP 20 mg coated tablets packaging label. The label indicates 90 tablets per package and includes the NDC number 71209-091-04. It specifies the product is for prescription use only and provides storage instructions along with the manufacturer's information: Cadila Pharmaceuticals Limited, Ahmedabad, India. Additional text mentions the spacing for the batch coding area on the label.*

FDA Label Image

Cont-label-90s-40mg.jpg (Cont Label 90s 40mg)

Atorvastatin Calcium Tablets, USP 40 mg coated tablet label from Cadila Pharmaceuticals Limited. The label indicates a package containing 90 tablets, Rx only, with storage instructions and manufacturer details from Ahmedabad, India. The label includes a barcode, NDC 71209-092-04, and dosing/warnings information.*

FDA Label Image

Cont-label-90s-80mg.jpg (Cont Label 90s 80mg)

Atorvastatin Calcium Tablets, USP 80 mg film-coated oral tablets manufactured by Cadila Pharmaceuticals Limited. The label indicates a package size of 90 tablets, Rx only. Storage instructions specify 20° to 25°C with allowed excursions. The label includes the NDC code 71209-093-04 and mentions dispensing in a tight container per USP standards.*

FDA Label Image

Table-10.jpg (Table 10)

A data table comparing lipid profile changes with Placebo and Atorvastatin Calcium Tablets at 10 mg, 20 mg, and 80 mg doses. It presents values for Triglycerides, Total-C, LDL-C, HDL-C, and non-HDL-C across different subject groups, showing mean changes with confidence intervals.*

FDA Label Image

Table-11 (Table 11)

A data table presenting median, minimum, and maximum values for various lipid measurements at baseline and median percent changes for Atorvastatin Calcium tablets at 10 mg and 80 mg doses. Lipid parameters include Total-C, Triglycerides, IDL-C + VLDL-C, and non-HDL-C, with associated percentage changes for each dosage strength.*

FDA Label Image

Table-12 (Table 12)

A data table comparing the effects of placebo and atorvastatin calcium tablets on various lipid parameters including Total Cholesterol (Total-C), LDL Cholesterol (LDL-C), HDL Cholesterol (HDL-C), Triglycerides (TG), and Apolipoprotein B. The table displays numerical values representing changes in these lipid levels.*

FDA Label Image

Table-7 (Table 7)

This table presents clinical data comparing cardiovascular and mortality endpoints between Atorvastatin 10 mg and 80 mg doses. It includes primary endpoints, components of primary endpoints, secondary endpoints, and components of all-cause mortality, with respective event counts, percentages, and hazard ratios with 95% confidence intervals.*

FDA Label Image

Table-8 (Table 8)

A data table showing lipid parameter changes across different doses of Atorvastatin Calcium tablets compared to placebo. Columns include Dose, N (sample size), and percentage changes in TC, LDL-C, Apo B, TG, and HDL-C. The table displays data for placebo and 10 mg, 20 mg, 40 mg, and 80 mg dosage groups.*

FDA Label Image

Table-9 (Table 9)

A data table presenting results from three clinical trials comparing the effects of Atorvastatin calcium tablets 10 mg with other statins on various lipid parameters, including Total-C, LDL-C, Apo B, TG, and HDL-C. Sample sizes and 95% confidence intervals for differences are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.